ProSciento manages the relationship between clinical trial sites and specialized method hubs. To ensure efficiencies for complex multi-site NASH studies, clinical trial sites are selected within geographic proximity of pre-qualified method hubs. This removes the burden from individual sites to procure access to specialized methods. This also broadens the number of sites that can participate in a study and increases access to patients who may be eligible to participate in those trials.

ProSciento has a network of method hubs that are specialized centers with capabilities in advanced technologies and procedures, such as cutting-edge imaging, circulating biomarkers, and tissue biopsies. These advanced method hubs are strategically located around the world so that they are within close geographic proximity to clinical trial sites to ensure access for sites and patients.